We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 29, 2022

Utilization of Perioperative Intravesical Chemotherapy During Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma

Urologic Oncology: Seminars and Original Investigations


Additional Info

Disclosure statements are available on the authors' profiles:

Urologic Oncology: Seminars and Original Investigations
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy
Urol. Oncol 2022 Aug 04;[EPub Ahead of Print], AP Kenigsberg, G Carpinito, SA Gold, X Meng, A Ghoreifi, H Djaladat, A Minervini, M Jamil, F Abdollah, JM Farrow, C Sundaram, R Uzzo, M Ferro, M Meagher, I Derweesh, Z Wu, J Porter, A Katims, R Mehrazin, A Mottrie, G Simone, AC Reese, DD Eun, AS Bhattu, ML Gonzalgo, U Carbonara, R Autorino, V Margulis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading